<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04415840</url>
  </required_header>
  <id_info>
    <org_study_id>COLPO-4</org_study_id>
    <nct_id>NCT04415840</nct_id>
  </id_info>
  <brief_title>Lugol's Solution in Addition to Acetic Acid During Colposcopy</brief_title>
  <official_title>Benefits of Using Lugol's Solution in Addition to Acetic Acid During Colposcopy in Women With Cervical Dysplasia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zydolab - Institute of Cytology and Immune Cytochemistry</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zydolab - Institute of Cytology and Immune Cytochemistry</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the benefits of using Lugol's solution in addition to acetic acid during colposcopy
      in women with cervical dysplasia.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 31, 2020</start_date>
  <completion_date type="Anticipated">April 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 25, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>additional identified dysplastic lesions on the cervix uteri due to the use of Lugol's Solution</measure>
    <time_frame>1 minute</time_frame>
    <description>We count all the cases in which dysplastic lesions on the cervix uteri where identified due to the use</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sensitivity</measure>
    <time_frame>1 minute</time_frame>
    <description>sensitivity of the examination (acetic acid + Lugol´s solution)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Specificity</measure>
    <time_frame>1 minute</time_frame>
    <description>Specificity of the examination (acetic acid + Lugol´s solution)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PPV</measure>
    <time_frame>1 minute</time_frame>
    <description>Positive predictive value of the examination (acetic acid + Lugol´s solution)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NPV</measure>
    <time_frame>1 minute</time_frame>
    <description>Negative predictive value of the examination (acetic acid + Lugol´s solution)</description>
  </secondary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Uterine Cervical Dysplasia</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>acetic acid test</intervention_name>
    <description>using acetic acid to unmask dysplastic lesions on the cervix uteri</description>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Lugol's solution test</intervention_name>
    <description>using Lugol's solution after acetic acid test to unmask dysplastic lesions on the cervix uteri</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Non-pregnant women referred for colposcopy due to cervical abnormalities
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  women referred for colposcopy due to cervical abnormalities

          -  written informed consent

        Exclusion Criteria:

          -  pregnant women

          -  presence of a language barrier

          -  history of conization or other treatments on the cervix uteri

          -  iodine allergy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Ziad Hilal, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zydolab - Institute of Cytology and Immune Cytochemistry</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ziad Hilal, M.D.</last_name>
    <phone>+0049 231 579349</phone>
    <email>z.hilal@zydolab.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Clemens B. Tempfer, M.D., MBA</last_name>
    <phone>+0049 2323 499 1801</phone>
    <email>clemens.tempfer@rub.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Zydolab - Institute of Cytology and Immune Cytochemistry</name>
      <address>
        <city>Dortmund</city>
        <state>NRW</state>
        <zip>44137</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ziad Hilal, M.D.</last_name>
      <phone>+0049 231 579349</phone>
      <email>z.hilal@zydolab.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Obstetrics and Gynecology of the Ruhr University Bochum</name>
      <address>
        <city>Herne</city>
        <state>NRW</state>
        <zip>44265</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clemens B. Tempfer, M.D., MBA</last_name>
      <phone>02323 499 1801</phone>
      <email>Clemens.Tempfer@rub.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 1, 2020</study_first_submitted>
  <study_first_submitted_qc>June 1, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 4, 2020</study_first_posted>
  <last_update_submitted>June 1, 2020</last_update_submitted>
  <last_update_submitted_qc>June 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cervical dysplasia</keyword>
  <keyword>colposcopy</keyword>
  <keyword>Lugol's solution</keyword>
  <keyword>acetic acid</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Uterine Cervical Dysplasia</mesh_term>
    <mesh_term>Cervical Intraepithelial Neoplasia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetic Acid</mesh_term>
    <mesh_term>Retinol acetate</mesh_term>
    <mesh_term>Lugol's solution</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

